raises the question of whether MS, as a demyelinating disease with associated retinal vasculitis, could be a risk factor for late-onset ARN in patients who have suffered previous herpetic encephalitis.
Sir
The role of IgM isotype anticardiolipin antibodies in occlusive ocular vascular disease: report of two cases with primary anti phospholipid antibody syndrome Several studies have clearly shown that the primary antiphospholipid antibody syndrome (PAPS) is associated with cerebral ischaemia and occlusive ocular vascular disease. 1 -7 Most of the studies that assayed for anticardiolipin (aCL) antibodies showed that the IgG isotype was clearly more frequent than the other two isotypes and is the only significant one among patients with cerebral ischaemia or ocular vascular thrombosis.
3 ,5,7 -11
We describe two PAPS patients with vaso-occlusive ocular disease in the presence of high-titre IgM aCL antibodies without a concomitant IgG isotype, and suggest that the IgM isotype is also associated with ocular vascular thrombosis in PAPS.
Case reports Case 1. A 40-year-old man noted decreased vision in his right eye in July 1998. His visual acuity in the right eye was 20/70 and in the left eye 20/20. The results of a colour vision test (Ishihara) were 7/12 in the right eye and 12/12 in the left eye. The anterior segment and intraocular pressure of both eyes were normal. On ophthalmoscopic examination, the right optic disc was oedematous; the veins looked tortuous and engorged and were surrounded by intraretinal haemorrhages and a few cotton wool spots. The left fundus appeared normal. Fluorescein angiography showed an increased venous transit time with staining of the retinal veins and leakage of fluorescein from dilated capillaries in the right eye and normal findings on the left side (Fig. 1) . MR imaging of the brain and routine laboratory tests were all normal except for a low platelet count (110 X 10 3 / J.11). The antinuclear antibody and anti-DNA test results were negative. Further coagulation studies showed an increased level of IgM aCL antibodies of 6.31 MPL (normal values: 0-1.10 MPL). The results of tests for VDRL, Lyme and HIV were negative. The patient had no history of exposure to certain drugs such as phenothiazines.
The patient was diagnosed as having central retinal vein occlusion due to primary antiphospholipid syndrome associated with IgM aCL antibodies. He was treated with warfarin and remained without further episodes during 9 months of follow-up. The latest neuro-ophthalmological examination revealed 20/20 vision in the right eye with a normal fundoscopic appearance (Fig. 1) . Case 2. A 28-year-old woman noted a sudden decrease in vision in the right eye in the first week of January 1999. Fifteen days later a similar symptom occurred in her left eye and she was evaluated in our department. She had no light perception in both eyes. The pupils were dilated and unreactive to light. The fundoscopic examination revealed optic nerve atrophy in the right eye and a swollen disc in the left eye. She had had an unexplained spontaneous abortion at approximately 16 weeks of gestation 2 years previously. MR imaging of the brain and orbits was normal. Routine laboratory tests and spinal fluid examination showed no abnormalities. The anti-DNA, antinuclear antibodies and rheumatoid factor were negative. The results of further coagulation tests were normal except for a significantly elevated level of IgM isotype (9.37 MPL). The tests for VDRL, Lyme and HIV were negative and there was no history of exposure to drugs.
The patient was considered to have bilateral consequent ischaemic optic neuropathy due to primary antiphospholipid antibody syndrome associated with IgM aCL antibodies. She received anticoagulant therapy with warfarin and has had no further episodes to date.
Comment
Previous studies have clearly demonstrated the relationship between PAPS and cerebral ischaemia and ocular disorders such as transient visual loss, diplopia, ischaemic optic neuropathy, retinal artery and retinal venous occlusion. 1 -7 Only a few of these studies that assayed for aCL antibodies, especially those related to antiphospholipid antibody syndrome and cerebral ischaemia, separated out the different isotypes and attempted to determine their Significance. The Antiphospholipid Antibodies in Stroke Study (AP ASS) Group prevalence study showed that the IgG isotype was clearly more frequent, and in that study as well, when it was evaluated independently, it was the only one that reached significance. s The study by Hess et al. l1 also noted that the IgG isotype was the only one significantly higher among patients with retinal or cerebral ischaemia than among controls.
It has been shown that antiphospholipid antibodies can also accompany malignancy, Guillain-Barre syndrome, myelopathy, haematological disorders such as idiopathic thrombocytopenic purpura (ITP), haemolytic anaemia, infections, including syphilis, infection with human immunodeficiency virus type I, Lyme disease, and variety of viral infections. 9 , 12 In addition, certain drugs, such as phenothiazines, have been associated with aPLs. In these settings, it is postulated that there seems to be a minimal association with thrombosis, thrombocytopenia or recurrent fetal loss, and the antibody characteristics differ from those generally associated with clinical symptoms, typically being of the IgM isotype and low titre. 9 To define the pathogenic role of IgM aCL antibodies in central retinal vein occlusion and bilateral ischaemic optic neuropathy, both patients were tested for the conditions strictly associated with IgM isotype. There were no evidence of the major clinical or serological features of the reviewed conditions and the elevated levels of IgM aCLs were attributed to vascular thrombosis in our patients.
In contrast to the accepted data, we support the view that high-titre IgM isotype aCL antibodies can accompany PAPS with central retinal vein occlusion and bilateral ischaemic optic neuropathy. Our findings suggest that the IgM isotype may play an important role in the pathogenesis of aCL antibody-associated thrombosis as well as immune-mediated non-vascular neurological injury such as Guillain-Barre syndrome, infections and drug exposure.
In conclusion, the recognition of the importance of IgM isotype aCL antibodies in the aetiology of our patients' vascular events directed our attention to their treatment and they were treated with warfarin appropriately.
